ArticleMedical oncology (Northwood, London, England)2022

Molecular docking, synthesis, and biological evaluation of 7-azaindole-derivative (7AID) as novel anti-cancer agent and potent DDX3 inhibitor:-an in silico and in vitro approach.

Ravinder Doneti et al.PubMed ↗Publisher ↗

No numbers read from the abstract.